Reactive capillary hemangiomas induced by camrelizumab (SHR-1210), an anti-PD-1 agent

Authors

  • Yan Teng Clinical Trials and Cosmetics Testing Center, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
  • Ruifeng Guo Dermatopathology Section, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
  • Jianfang Sun Department of Pathology, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
  • Yi Liu Clinical Trials and Cosmetics Testing Center, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China

DOI:

https://doi.org/10.1080/0284186X.2019.1567935

Abstract

  No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-03-04

How to Cite

Teng, Y. ., Guo, R. ., Sun, J. ., & Liu, Y. . (2019). Reactive capillary hemangiomas induced by camrelizumab (SHR-1210), an anti-PD-1 agent. Acta Oncologica, 58(3), 388–389. https://doi.org/10.1080/0284186X.2019.1567935

Issue

Vol. 58 No. 3 (2019): Acta Oncologica

Section

Articles